Zuellig Pharma Strengthens Clinical Sourcing Capabilities in China through Strategic Acquisition

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Zuellig-Pharma

More Like This

PR Newswire associated0

Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License

PR Newswire associated0

Taiwan Showcases Integrated Pharma Supply Chain Solutions at CPHI Milan 2026 Amid Global Restructuring

WuXi Biologics Germany to Enhance Capabilities with New Prefilled Syringes Line

PR Newswire associated0

Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production

PR Newswire associated0

ESTEVE CDMO strengthens its global manufacturing footprint with a major investment and new site in China

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

PR Newswire associated0

Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites

PR Newswire associated0

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market